Life ScienceCompany
Assertio Therapeutics - NUCYNTA Ownership
Who owns Assertio Therapeutics - NUCYNTA?
Assertio Therapeutics - NUCYNTA is owned by Collegium Pharmaceutical. It was acquired on February 6, 2020.
Assertio Therapeutics - NUCYNTA Business Overview
Where is Assertio Therapeutics - NUCYNTA headquartered?
Assertio Therapeutics - NUCYNTA is headquartered in California.
What sector is Assertio Therapeutics - NUCYNTA in?
Assertio Therapeutics - NUCYNTA is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.